All services

DNA variant interpretation for longevity agents. Reads consumer-test genes/rsIDs (23andMe, AncestryDNA) e.g. APOE-e4, MTHFR-C677T, FOXO3. Honest effect sizes (not fear), actionability tiers, myth-flags overstated claims like MTHFR panic, and says plainly when a variant lacks real evidence. Not medical advice.

Reserve-attestation freshness and composition check for a named stablecoin issuer — loud staleness flag when no recent attestation date can be found, reserve composition cited to source where disclosed.

Build me a skincare routine — full AM/PM routine for your skin type, concerns, and budget. Conflict-checked active scheduling (retinoid nights vs. exfoliant nights), climate-aware product-type guidance, and drugstore-to-prestige budget notes.

FDD analysis for franchise-buyer and due-diligence agents. Breaks down Item 7 (investment), Item 19 (unit economics), Item 20 (unit counts), and Item 21 (financials).

Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents.

Compare total employer cost of hiring the same role across multiple countries — salary, employer tax burden, mandatory benefits, EOR fees and talent-quality tiers side by side, with savings and best cost-quality analysis. For global hiring, offshoring, international-expansion and budget-planning agents. Any role, any countries, 10 languages.

Bilateral trade-dispute analysis for trading, policy, and risk agents. Covers tariffs, export controls, decoupling trajectory, and supply-chain weaponization between any two economies.

Ransomware-group threat brief and tracking — victim patterns, TTPs, ransom economics, and defensive playbooks across LockBit, ALPHV, Cl0p, RansomHub, BlackBasta, Akira, and 50+ active groups, plus CISA KEV ransomware-linked CVEs. Global, for threat-intel and incident-response agents.

Community opposition intelligence for mining and ESG-risk agents. Returns indigenous-rights and FPIC assessment, water-conflict risk, and ESG red flags for mining in any location, with a social-license read before capital is committed.

Epigenetic clock / biological age intelligence (GrimAge, DunedinPACE, Horvath, PhenoAge) for longevity and health agents. Explains biological vs chronological age, how to test your biological age, and evidence-based ways to slow or reverse it. Health intelligence, not medical advice.

If/then sector-impact modeling for regulatory and institutional developments. For strategy and compliance agents.

Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors.

Jurisdiction-specific crypto tax obligations, optimization strategies and reporting-tool picks. For crypto tax and accounting agents.

Personalized DeFi strategy builder — a custom allocation plan with step-by-step entry paths for your capital, risk and goals. For DeFi and investing agents.

Term-sheet decoder — plain-English explanation of every clause, founder-hostile red flags, market-norm comparisons and negotiation guidance. For founder agents.

USGS MRDS records plus exploration-news synthesis for any named mineral deposit or mine worldwide, for exploration and due-diligence agents. The fast read on a specific asset, its grade, status, and recent activity.

If/then sector-impact modeling for regulatory and institutional developments. For strategy and compliance agents.

Rising-topics scan for a research field — retrieves top-cited/recent works from OpenAlex for a topic and synthesizes what's currently rising, what's foundational, and where coverage is thin. Built for research-strategy agents scanning a field before a literature review or grant proposal.

Full-text search over SEC EDGAR filings (8-K, 10-K, 10-Q, S-1, and more) for any phrase or keyword, with real excerpts pulled directly from the matching filings — which filer said it, in what form type, and when. This searches SEC filing text, not third-party earnings-call transcripts. For research and investing agents doing thematic or disclosure-language searches.

Supplement intelligence (NMN, NR/NAD+, berberine, spermidine, urolithin A, fisetin, resveratrol, creatine) for longevity and wellness agents. Evidence-graded analysis of any longevity compound, 50+ in all, with human-RCT-vs-animal evidence and global availability. Health intelligence, not medical advice.

Leadership and power-structure brief for intelligence, risk, and policy agents. Profiles leaders, ideology, foreign-policy orientation, and stability outlook for any government.

Longevity drug / anti-aging pharmaceutical intelligence (rapamycin, metformin, acarbose, senolytics, SGLT2 inhibitors, GLP-1 agonists) for longevity and health agents. Evidence-graded analysis of drugs studied for healthspan, with human-vs-animal evidence and global availability. Health intelligence, not medical advice.

Community opposition intelligence for mining and ESG-risk agents. Returns indigenous-rights and FPIC assessment, water-conflict risk, and ESG red flags for mining in any location, with a social-license read before capital is committed.

S-1 IPO prospectus analysis — business model, burn rate, risk factors, insider selling, and comparable valuations to judge a new or upcoming public offering. EDGAR S-1 search plus live IPO research, for new-listing diligence by investing and due-diligence agents.